James Vane
Stock Analyst at Jefferies
(0.71)
# 3,782
Out of 4,334 analysts
469
Total ratings
48.3%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BME: ROVI Laboratorios Farmaceuticos Rovi, S.A. | Maintained: Hold | $84 → $64 | $60.10 | +6.82% | 9 | May 13, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | $769 → $762 | $492.80 | +54.63% | 12 | May 13, 2026 | |
| SWX: SFZN Siegfried Holding AG | Maintained: Hold | $95 → $88 | $80.25 | +9.66% | 3 | May 13, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | $16 | $16.90 | -8.28% | 9 | May 13, 2026 | |
| ETR: SHL Siemens Healthineers AG | Maintained: Buy | $49 → $60 | $35.12 | +70.84% | 24 | May 7, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | $57 → $55 | $38.44 | +43.08% | 80 | May 6, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | $2,360 → $1,870 | $1,459.00 | +28.17% | 27 | May 5, 2026 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Sell | $32 | $37.64 | -14.98% | 90 | May 5, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | $75 → $84 | $64.44 | +30.35% | 5 | May 5, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | $110 | $119.46 | -7.92% | 2 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $307 | $234.50 | +30.92% | 34 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $204 → $188 | $165.40 | +13.66% | 3 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.87 → $8.27 | $618.00 | -98.66% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 → $246 | $187.60 | +31.13% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $229 → $262 | $173.10 | +51.36% | 13 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $27.00 | +26.30% | 40 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.80 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,250 → $1,420 | $1,199.00 | +18.43% | 15 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $333 → $368 | $362.50 | +1.52% | 12 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $49 | $78.50 | -37.20% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $298 | $222.50 | +33.93% | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13,390 → $13,837 | $39.55 | +34,886.09% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $49 → $62 | $51.55 | +19.30% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $17 → $18 | $21.64 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9.3 → $11 | $11.37 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.49 | $4.24 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $147 → $148 | $89.90 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $197.00 | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $630 → $1,150 | $405.36 | n/a | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $135 → $43 | $15.09 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $29 | $71.50 | n/a | 1 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $15.52 | n/a | 2 | Jan 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.14 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $213.50 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 | $13.60 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $39.20 | n/a | 1 | Aug 21, 2017 |
Laboratorios Farmaceuticos Rovi, S.A.
May 13, 2026
Maintained: Hold
Price Target: $84 → $64
Current: $60.10
Upside: +6.82%
Lonza Group AG
May 13, 2026
Maintained: Buy
Price Target: $769 → $762
Current: $492.80
Upside: +54.63%
Siegfried Holding AG
May 13, 2026
Maintained: Hold
Price Target: $95 → $88
Current: $80.25
Upside: +9.66%
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: $16
Current: $16.90
Upside: -8.28%
Siemens Healthineers AG
May 7, 2026
Maintained: Buy
Price Target: $49 → $60
Current: $35.12
Upside: +70.84%
Fresenius SE & Co. KGaA
May 6, 2026
Maintained: Buy
Price Target: $57 → $55
Current: $38.44
Upside: +43.08%
Hikma Pharmaceuticals PLC
May 5, 2026
Reiterated: Buy
Price Target: $2,360 → $1,870
Current: $1,459.00
Upside: +28.17%
Fresenius Medical Care AG
May 5, 2026
Maintained: Sell
Price Target: $32
Current: $37.64
Upside: -14.98%
Sandoz Group AG
May 5, 2026
Maintained: Buy
Price Target: $75 → $84
Current: $64.44
Upside: +30.35%
Novartis AG
Apr 28, 2026
Maintained: Hold
Price Target: $110
Current: $119.46
Upside: -7.92%
Apr 23, 2026
Maintained: Buy
Price Target: $307
Current: $234.50
Upside: +30.92%
Apr 21, 2026
Maintained: Hold
Price Target: $204 → $188
Current: $165.40
Upside: +13.66%
Mar 23, 2026
Maintained: Buy
Price Target: $6.87 → $8.27
Current: $618.00
Upside: -98.66%
Mar 18, 2026
Maintained: Buy
Price Target: $210 → $246
Current: $187.60
Upside: +31.13%
Mar 17, 2026
Maintained: Buy
Price Target: $229 → $262
Current: $173.10
Upside: +51.36%
Feb 2, 2026
Maintained: Buy
Price Target: $34
Current: $27.00
Upside: +26.30%
Jan 16, 2026
Maintained: Hold
Price Target: n/a
Current: $23.80
Upside: -
Oct 29, 2025
Maintained: Hold
Price Target: $1,250 → $1,420
Current: $1,199.00
Upside: +18.43%
Oct 22, 2025
Maintained: Hold
Price Target: $333 → $368
Current: $362.50
Upside: +1.52%
Sep 25, 2025
Initiated Coverage: Sell
Price Target: $49
Current: $78.50
Upside: -37.20%
Aug 15, 2025
Maintained: Buy
Price Target: $260 → $298
Current: $222.50
Upside: +33.93%
Aug 15, 2025
Maintained: Buy
Price Target: $13,390 → $13,837
Current: $39.55
Upside: +34,886.09%
Aug 11, 2025
Upgraded: Buy
Price Target: $49 → $62
Current: $51.55
Upside: +19.30%
Aug 8, 2024
Maintained: Sell
Price Target: $17 → $18
Current: $21.64
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $9.3 → $11
Current: $11.37
Upside: n/a
Jan 5, 2024
Maintained: Hold
Price Target: $4.49
Current: $4.24
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $147 → $148
Current: $89.90
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: $3
Current: $197.00
Upside: n/a
Feb 8, 2022
Initiated Coverage: Buy
Price Target: $630 → $1,150
Current: $405.36
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: $135 → $43
Current: $15.09
Upside: n/a
Aug 27, 2021
Maintained: Sell
Price Target: $29
Current: $71.50
Upside: n/a
Jan 20, 2020
Downgraded: Sell
Price Target: n/a
Current: $15.52
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $8.14
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $93
Current: $213.50
Upside: n/a
Nov 1, 2017
Maintained: Sell
Price Target: $31
Current: $13.60
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $39.20
Upside: n/a